Cite
Vogel JP, Oladapo OT, Pileggi-Castro C, et al. Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials. BMJ Glob Health. 2017;2(3):e000398doi: 10.1136/bmjgh-2017-000398.
Vogel, J. P., Oladapo, O. T., Pileggi-Castro, C., Adejuyigbe, E. A., Althabe, F., Ariff, S., Ayede, A. I., Baqui, A. H., Costello, A., Chikamata, D. M., Crowther, C., Fawole, B., Gibbons, L., Jobe, A. H., Kapasa, M. L., Kinuthia, J., Kriplani, A., Kuti, O., Neilson, J., Patterson, J., Piaggio, G., Qureshi, R., Qureshi, Z., Sankar, M. J., Stringer, J. S. A., Temmerman, M., Yunis, K., Bahl, R., & Metin Gülmezoglu, A. (2017). Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials. BMJ global health, 2(3), e000398. https://doi.org/10.1136/bmjgh-2017-000398
Vogel, Joshua P, et al. "Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials." BMJ global health vol. 2,3 (2017): e000398. doi: https://doi.org/10.1136/bmjgh-2017-000398
Vogel JP, Oladapo OT, Pileggi-Castro C, Adejuyigbe EA, Althabe F, Ariff S, Ayede AI, Baqui AH, Costello A, Chikamata DM, Crowther C, Fawole B, Gibbons L, Jobe AH, Kapasa ML, Kinuthia J, Kriplani A, Kuti O, Neilson J, Patterson J, Piaggio G, Qureshi R, Qureshi Z, Sankar MJ, Stringer JSA, Temmerman M, Yunis K, Bahl R, Metin Gülmezoglu A. Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials. BMJ Glob Health. 2017 Aug 30;2(3):e000398. doi: 10.1136/bmjgh-2017-000398. eCollection 2017. PMID: 29082019; PMCID: PMC5656119.
Copy
Download .nbib